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We have investigated whether granzyme B (GzmB) is required for effective cytotoxic T lymphocyte (CTL) mediated control
of lymphocytic choriomeningitis virus (LCMV) infection. Clearance of LCMV from tissues of GzmB-deficient (GzmB) mice
following intraperitoneal infection with LCMV was impaired compared with control mice; however, the virus was ultimately
eliminated. The impaired clearance of LCMV in GzmB mice was not due to a deficiency in the generation of LCMV-specific
T cells. In addition, CTL from LCMV-infected GzmB mice efficiently lysed virus-infected cells in vitro, but were deficient in
their ability to induce rapid DNA fragmentation in target cells. We examined whether the development of protective immunity
against intracranial (i.c.) rechallenge with LCMV was compromised in GzmB mice. We found that clearance of LCMV from
the brain following secondary i.c. infection also was slower in the absence of GzmB; however, the virus was ultimately
eliminated and the mice survived. Our data indicate that clearance of LCMV is delayed in the absence of GzmB expression,
but that other CTL effector molecules can compensate for the absence of this granule constituent in vivo. © 2002 ElsevierKey Words: granzyme B; LCMV; cytotoxic T lymphocyte.
INTRODUCTION
T cells play a critical role in the immune response
against viral infections. In general, the antiviral effects of
T cells are mediated through the release of antiviral
cytokines or via direct killing of virus-infected cells by
cytotoxic T lymphocytes (CTL) (reviewed by Doherty and
Ahmed, 1997; Zinkernagel, 1996). Control of infection with
noncytopathic viruses, such as lymphocytic choriomen-
ingitis virus (LCMV), is crucially dependent on CD8 CTL.
Infection of normal mice with LCMV induces high levels
of virus-specific CD8 CTL activity and the virus is cleared
within 8–10 days following infection. By contrast, mice
deficient in CD8 T cells fail to control LCMV and become
persistently infected (Leist et al., 1987; Moskophidis et
al., 1987; Zajac et al., 1995). Since clearance of acute
infection with LCMV is solely dependent on CD8 CTL
(Leist et al., 1987; Moskophidis et al., 1987), infection with
this virus provides a useful system with which to study
the effector mechanisms of CD8 CTL in vivo.
Two major pathways of CTL-mediated cytotoxicity
have been described. These are the secretory and non-
secretory pathways (Ka¨gi et al., 1994a,b; Lowin et al.,
1994; Kojima et al., 1994). In the nonsecretory pathway,
the interaction between Fas ligand (FasL) on the surface
of the activated CTL and Fas on the surface of the target
cell results in apoptotic death of the target cell. This1pathway of target cell killing is frequently used by CD4
CTL (Graubert et al., 1997; Zajac et al., 1996) but can be
also utilized by CD8 CTL (Ka¨gi et al., 1994b; Lowin et al.,
1994; Kojima et al., 1994). The major pathway of cytotox-
icity utilized by CD8 CTL, however, is the secretory path-
way. In this pathway, the release of perforin from gran-
ules contained within activated CTL leads to the forma-
tion of polyperforin pores in the membrane of the target
cell, resulting in loss of membrane integrity. The CTL
granules also contain enzymes called granzymes. The
major granzymes released by CD8 CTL are granzyme A
(GzmA) and GzmB. Of these, GzmB has been shown to
bind to a specific receptor on target cell membranes
(Motyka et al., 2000) and to induce rapid apoptosis of
target cells in vitro (Simon et al., 1997). Upon entering the
target cell, GzmB is thought to proteolytically activate
several caspases culminating in DNA fragmentation and
in the rapid apoptotic death of the target cell (Darmon et
al., 1995; Duan et al., 1996; Gu et al., 1996; Quan et al.,
1996; Talanian et al., 1997). In addition, GzmB has been
reported to directly induce apoptosis independent of
caspase activation (Andrade et al., 1998; Talanian et al.,
1997).
The primacy of the secretory pathway of CTL-medi-
ated killing for the elimination of LCMV infection has
been conclusively demonstrated in studies using mice
deficient in perforin (Ka¨gi et al., 1994a, 1995b; Walsh et
al., 1994). Perforin-deficient mice do not have detectableScience (USA)
1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (708) 216-9574.
Virology 305, 1–9 (2003)
doi:10.1006/viro.2002.1754Fas-independent CTL and, consequently, fail to control
infection with LCMV. It is unclear, however, whether0042-6822/02 $35.00
© 2002 Elsevier Science (USA)
All rights reserved.
perforin-mediated loss of membrane integrity is suffi-
cient for elimination of LCMV-infected cells in vivo or if
rapid induction of target cell apoptosis is also required.
In this study we have investigated whether GzmB ex-
pression and, consequently, the rapid GzmB-dependent
induction of DNA fragmentation in target cells are critical
for CTL-mediated control of LCMV infection of mice.
RESULTS
Kinetics of virus clearance in GzmB mice
We initially examined whether GzmB mice could con-
trol infection with the noncytopathic virus, LCMV. Infec-
tion of normal mice with LCMV results in peak viral titers
in spleens and livers at day 4 postinfection, following
which virus is controlled and eliminated by 8–10 days
postinfection (Fig. 1). That this control is dependent on
CTL is illustrated by the persistent infection that occurs
in Pfp mice (Fig. 1) (Ka¨gi et al., 1994a; Walsh et al., 1994).
Because the GzmB mice used in this study were on a
mixed B6x129 genetic background, we also assessed
virus clearance from spleens and livers of control B6x129
mice (B6129SF2/J mice). We found no difference in the
kinetics of clearance of LCMV from tissues of B6 mice
and from tissues of B6129SF2/J mice. The control mice
indicated in Fig. 1 represent three B6 mice and three
B6129SF2/J mice at each time point. The levels of virus in
both spleens and livers of GzmB mice were similar to
the levels in these tissues of control mice up to 4 days
following infection. In contrast to control mice, however,
peak viral titers are maintained in GzmB mice until day
6 following intraperitoneal (ip) infection. By day 8 after
infection splenic viral titers are substantially reduced in
GzmB mice, but the levels of virus are still significantly
higher than the levels detected in the spleens of control
mice at this time point. By contrast, although the viral
titers in livers seem somewhat higher in GzmB mice
than B6 mice at this time point, this difference was not
significant. By 10 days after infection, infectious virus is
undetectable in spleens and livers of GzmB mice and
these animals remain virus-free for greater than 120 days
following infection (data not shown).
Expansion of virus-specific T cells in GzmB mice
Since acute infection with LCMV is controlled by CTL,
we reasoned that the delayed clearance of LCMV by
GzmB CTL could be due to either of two possibilities.
First, the effector function of GzmB cells could be suf-
ficiently compromised such that they function less effi-
ciently in vivo. Second, it is possible that the GzmB mice
used in this study generated fewer numbers of virus-
specific T cells following infection with LCMV. We first
addressed the possibility that the delayed clearance of
LCMV in GzmB mice is due to the expansion of fewer
virus-specific T cells compared with normal mice. We
enumerated T cells specific for the immunodominant
viral CD4 and CD8 epitopes at various times following ip
infection with LCMV using ELISPOT to detect IFN--
secreting cells. There is a good correlation between the
numbers of IFN- producing CD8 cells and the total
numbers of virus-specific cells (Murali-Krishna et al.,
1998). As previously demonstrated (Butz and Bevan,
1998; Kamperschroer and Quinn, 1999; Murali-Krishna et
al., 1998), the numbers of virus-specific CD8 cells peak at
8 days postinfection with LCMV (Figs. 2A–2C). At this
time point there are, combined, approximately 5  107
cells in the spleen that are specific for the three domi-
nant class I restricted epitopes of LCMV. The numbers of
virus-specific cells subsequently decline with approxi-
mately 2 106 cells being maintained for greater than 90
days following infection. As seen in Fig. 2, the numbers
of virus-specific CD8 cells that are generated and main-
tained in GzmB mice are indistinguishable from the
numbers of these cells in B6 mice. Since CD4 cells are
important in promoting and maintaining the function of
CD8 cells (Battegay et al., 1994; Matloubian et al., 1994;
von Herrath et al., 1996; Zajac et al., 1998), we examined
FIG. 1. Kinetics of clearance of LCMV from spleens and livers of
GzmB mice. Mice were infected with 2  105 PFU of LCMV. Spleens
(A) and livers (B) were removed at the indicated times following infec-
tion and viral titers were determined by plaque assay on Vero cell
monolayers. , wild-type mice, n  6 at each time point (three B6 and
three B6129S2/J); Œ, GzmB mice, n  5 at each time point; F, Pfp
mice, n  3 at each time point. Data shown are the means  SEM of
the viral titers in spleens at each time point. *P  0.01; **P  0.05.
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whether the defect in virus clearance that we observe in
GzmB mice could be explained by inefficient expansion
of virus-specific CD4 cells. Using ELISPOT, we enumer-
ated T cells specific for the immunodominant I-Ab-re-
stricted epitopes of LCMV in spleens of infected mice.
We found that the numbers of epitope-specific I-Ab-re-
stricted cells in spleens of GzmB mice were similar to
the numbers of these cells in spleens of B6 mice at all
time points following infection with LCMV (Figs. 2D–2E).
In addition, the percentages of CD4 cells and CD8 cells
in spleens of GzmB and B6 mice following infection
were similar at all time points examined (data not
shown).
Together these data indicate that the impaired clear-
ance of LCMV from GzmB mice is not due to expansion
of insufficient numbers of virus-specific T cells. We next
examined whether the epitope-specific CD8 cells gener-
ated during LCMV infection of GzmB mice were capa-
ble of killing virus-infected cells in vitro.
Virus-specific cytolytic activity by GzmB CTL
Since clearance of LCMV requires cytolytic T cell func-
tion (Ka¨gi et al., 1994a; Walsh et al., 1994), we examined
whether GzmB T cells could efficiently kill LCMV-in-
fected target cells in vitro. As shown in Figs. 3A and 3B,
FIG. 2. Numbers of LCMV-specific T cells following infection of B6 and GzmB mice. Spleen cells were prepared from B6 mice (F) and from GzmB
mice (E) at the indicated days after ip infection with LCMV. The numbers of spleen cells that secrete IFN- in response to stimulation with the class
I restricted LCMV epitopes GP33-41 (A), NP396-404 (B), or GP276-286 (C), and with the class II restricted epitopes GP61-80 (D) or NP309-328 (E) were
determined by ELISPOT. Data shown are the means  SEM of the numbers of epitope-specific cell/spleen from a minimum of three mice at each
time point.
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spleen cells taken from B6 and GzmB mice 8 days after
infection with LCMV are equally potent at killing LCMV-
infected target cells in vitro as measured using a 51Cr-
release assay. Since the target cells used in this assay
do not express Fas, this assay is not measuring Fas-
FasL-dependent cytotoxicity. Furthermore, the inability of
effector cells from Pfp mice to kill the infected target
cells indicates that this assay is measuring perforin-
dependent killing activity. We next measured the ability of
the effector cells to induce DNA fragmentation in the
target cells using the JAM assay. In contrast to cells from
B6 mice, the GzmB cells are unable to induce rapid
(within 4 h) DNA fragmentation in infected target cells
(Fig. 3C). However, LCMV-infected target cells exposed
to GzmB CTL undergo DNA fragmentation by 8 h of
culture (Fig. 3D). Overall, these data indicate that LCMV
infection of GzmB mice results in expansion of virus-
specific CTL, which kill infected cells in vitro using the
secretory pathway of CTL-mediated lysis, but which fail
to induce rapid apoptosis of LCMV-infected cells. Our
finding that clearance of LCMV is impaired in the ab-
sence of GzmB suggests that this inability of GzmB
cells to induce rapid apoptosis of LCMV-infected cells is
of consequence in vivo.
Control of secondary infection in GzmB mice
The basis of protective immunity is that the memory
cells generated following an initial exposure to a patho-
gen will allow for a more rapid response against that
same pathogen upon secondary exposure. We wished to
examine whether GzmB CTL could eliminate virus suf-
ficiently rapidly to protect the host from a normally lethal
challenge with LCMV. Infection of naı¨ve B6 or GzmB
mice intracranially (i.c.) with LCMV results in death (Fig.
4). All mice that were depleted of CD8 cells prior to
infection survived as expected, since lethal LCMV dis-
ease results from CTL-mediated destruction of infected
cells in the brain (Baenziger et al., 1986; Leist et al., 1987;
Moskophidis et al., 1987). Normal mice that have previ-
ously been exposed to LCMV are protected from lethal
immunopathology following i.c. rechallenge with LCMV
because they have developed protective immunity
against this virus (Borrow and Oldstone, 1997; Buch-
meier and Zajac, 1998). Similar to wild-type mice, we
found that GzmB animals also survived secondary i.c.
infection with LCMV (Fig. 4). However, brain tissue taken
from GzmB mice 3 days after i.c. rechallenge with 2 
103 PFU LCMV contained 10 to 100 times more infectious
virus than brains from B6 mice at the same time point
(Fig. 5). These data indicate that GzmB mice are not
only compromised in their ability to control peripheral
infection with LCMV, but are also less efficient at con-
trolling LCMV infection within the CNS. The virus was,
however, eliminated from the brains of GzmB mice by
day 4 following rechallenge with no overt detrimental
effect on the host. Similar results were obtained when
animals were rechallenged i.c. with 2  105 PFU LCMV
(data not shown).
Since LCMV is cleared from the CNS by CD8 T cells,
we next examined whether the delayed clearance of
LCMV from the brains of GzmB mice was due to de-
FIG. 4. Protective immunity against secondary i.c. infection. Nonin-
fected mice (1°, broken lines) or mice that had been infected ip three
months previously with LCMV (2°, solid lines) were infected i.c. with
2  103 PFU of LCMV. One group of naive GzmB mice was depleted
of CD8 cells prior to i.c. infection with LCMV. The groups of mice are
indicated on the figure. All of the B6 and GzmB mice that had been
previously infected ip with LCMV survived the i.c. rechallenge; conse-
quently the lines representing these groups of mice are superimposed
on the figure. Each group consisted of either five or six mice.
FIG. 3. Virus-specific cytolytic activity. B6 and GzmB mice were
infected ip with 2  105 PFU of LCMV. Eight days later, spleen cells
from these mice were tested for cytotoxic activity against LCMV in-
fected (solid lines) and noninfected (broken lines) MC57 cells using
51Cr-release assays (A, B) or JAM assays (C, D). The assays were
incubated for either 4 h (A, C) or 8 h (B, D). F, B6; , GzmB; Œ, Pfp.
Representative results from four (A, B) and three (C, D) independent
experiments are shown.
4 ZAJAC, DYE, AND QUINN
creased accumulation of virus-specific CD8 cells in this
tissue. Using ELISPOT, we enumerated virus-specific
CD8 cells in brains of B6 and GzmB mice 3 days
following i.c. rechallenge with LCMV. As shown in Fig. 6,
there were equivalent numbers of CD8 cells infiltrating
the brains of GzmB and B6 mice that were specific for
the immunodominant GP33-41 and NP396-404 class I
restricted epitopes. This indicates that the elevated titers
of LCMV detected in the brains of GzmB mice at this
time point is not due to impaired infiltration of the CNS by
virus-specific CD8 cells.
DISCUSSION
It has been argued that the major mechanism whereby
the immune system rids the body of noncytopathic viral
infections is dependent on CTL (Ka¨gi et al., 1995a,b). The
requirement for perforin-dependent CD8 T cells for elim-
ination of the classic noncytopathic virus, LCMV, has
been clearly demonstrated (Ka¨gi et al., 1994a,b; Leist et
al., 1987; Moskophidis et al., 1987; Walsh et al., 1994;
Zajac et al., 1995). It is unclear, however, what role the
other components of the secretory pathway of CTL killing
play in clearance of this virus. To begin to address this
question, we have studied the course of LCMV infection
in mice that are genetically deficient in GzmB expres-
sion. Following ip infection, LCMV replicates to similar
levels in GzmB mice and control mice, and peak viral
titers in spleens and livers of these animals are attained
by day 4 following infection. However, peak viral titers in
these tissues are maintained for at least 2 days longer in
GzmB animals than are the peak titers in tissues of
control mice. Consequently, the virus is cleared some-
what later from spleens of GzmB mice than it is from
wild-type mice. These data indicate a role for GzmB in
efficient clearance of LCMV in vivo.
We next determined whether the delayed clearance of
LCMV by GzmB mice could be explained by impaired
expansion of virus-specific T cells in these animals. We
found that GzmB and B6 mice had equivalent numbers
of virus-specific CD4 and CD8 T cells at all time points
examined following infection. This indicates that the de-
lay in clearance of virus from these animals cannot be
explained by a failure to generate sufficient numbers of
antiviral T cells. It has been conclusively demonstrated
that clearance of acute infection with LCMV is depen-
dent on CD8 T cells (Leist et al., 1987; Moskophidis et al.,
1987). Since we found no difference in the numbers of
CD8 T cells that are generated following LCMV infection
in GzmB mice compared with B6 mice, we reasoned
that the impaired clearance of LCMV that we observed in
GzmB mice must be due to a difference in the function
of these T cells. We therefore examined the cytolytic
activity of spleen cells from LCMV-infected GzmB mice
in vitro. Our assays demonstrated that GzmB spleen
cells were competent to lyse LCMV-infected target cells
in vitro, but that, as expected, these cells were incapable
of inducing rapid DNA fragmentation in target cells. After
a longer incubation, GzmB cells did induce DNA frag-
mentation in LCMV-infected target cells. This later effect
is most likely due to GzmA (Simon et al., 1997; Shresta et
al., 1999). Our finding that clearance of LCMV is delayed
in GzmB mice suggests that this GzmB-dependent early
pathway of apoptosis induction is relevant in vivo during
CTL-mediated elimination of this virus.
Several studies have addressed the role of GzmA and
GzmB in immune-mediated control of virus infections.
Mu¨llbacher and colleagues (Mu¨llbacher et al., 1999) ex-
amined the response of Gzm mice to infection with the
poxvirus ectromelia. They found that GzmA and GzmB
mice were approximately 10 times and 100 times more
sensitive to infection with this virus, respectively, than
were wild-type mice. This same group also demon-
FIG. 6. Numbers of virus-specific CD8 cells in brains 3 days after i.c.
rechallenge. Groups of four GzmB (open bars) and four B6 mice (solid
bars) that had been infected ip 3 months previously with LCMV were
infected i.c. with 2 103 PFU LCMV. Three days after i.c. infection, mice
were sacrificed and mononuclear cells were isolated from the brains.
The numbers of GP33-41- and NP396-404-specific cells in the brains
were determined by ELISPOT. The numbers of epitope-specific cells in
brains of noninfected mice were below the level of detection of the
assay. Bars represent the means  SEM of the numbers of cells/g of
brain.
FIG. 5. Viral titers in brains three days after i.c. rechallenge. Groups
of three naive GzmB mice or of three GzmB and three B6 mice that
had been infected ip 3 months previously with LCMV were infected i.c.
with 2  103 PFU LCMV. Another group of previously infected GzmB
mice (n  3) was depleted of CD8 cells prior to i.c. rechallenge with
LCMV. Three days after i.c. infection, viral titers in brains were deter-
mined by plaque assay. The horizontal bars indicate the mean value for
each group. *P  0.01 compared with B6.
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strated that GzmA and GzmB mice were more suscep-
tible to murine cytomegalovirus (MCMV) infection (Riera
et al., 2000). In each of these reports the enhanced
susceptibility of GzmB mice, compared with controls, to
infection with the respective virus was substantially
greater than what we observe with LCMV infection. This
might be due to the role played by natural killer (NK) cells
in each of these infections. Similar to CTL, NK cells
secrete perforin and granzymes and exert potent antiviral
activity early following infection with poxviruses (Delano
and Brownstein, 1995) and with MCMV (Bukowski and
Welsh, 1985; Orange and Biron, 1996). The impairment of
NK activity during infection with ectromelia and MCMV
might allow these viruses to replicate to high levels early
following infection. By contrast, acute LCMV infection is
controlled by CTL and is insensitive to the antiviral ac-
tions of NK cells (Orange and Biron, 1996). In light of this
it is not surprising that we only observe elevated titers of
LCMV in GzmB mice beginning at day 6 after infection,
the time at which the virus is being brought under control
by CTL in normal mice. Another study also has ad-
dressed the role of granzymes and perforin in control of
LCMV infection (Balkow et al., 2001). These authors re-
ported no difference in the kinetics of clearance of LCMV
from livers of GzmB mice and control mice. However,
the earliest time point at which these authors measured
viral titers was day 8 after infection. At this time point we
also find no difference between the viral titers in livers of
GzmB mice and control mice (Fig. 1B). Balkow et al. did
not examine the kinetics of clearance of LCMV from
spleens of GzmB mice.
The studies alluded to above using ectromelia virus
(Mu¨llbacher et al., 1999) and MCMV (Riera et al., 2000),
as well as studies using herpes simplex virus (Pereira et
al., 2000), also revealed a role for GzmA in control of
these pathogens. By contrast, the lack of GzmA does not
appear to influence the outcome of infection with LCMV
(Ebnet et al., 1995); however, without a thorough analysis
of the kinetics of virus elimination it is possible that a
slight delay in virus clearance could have gone undetec-
ted in that study. That GzmA cannot totally compensate
for the absence of GzmB would not be surprising, how-
ever, as these enzymes have different substrate speci-
ficities and induce apoptosis via disparate pathways.
Although clearance of LCMV is somewhat delayed in
GzmB mice, GzmB is not absolutely required for elimi-
nation of this virus. We reasoned, however, that the
delayed kinetics of virus clearance in GzmB mice might
compromise their ability to generate a protective immune
response against secondary infection with LCMV. Three
days following i.c. rechallenge with LCMV, the levels of
virus in the brains of GzmB mice were elevated com-
pared with viral titers in brains of B6 mice. As with
peripheral infection, the virus was ultimately cleared
from the brains of GzmB mice and the animals survived.
The delayed clearance of LCMV from the brains of
GzmB mice is not due to impaired trafficking of CTL into
the infected CNS. We found no difference in the numbers
of LCMV-specific CD8 cells infiltrating the brains of in-
fected GzmB mice and the numbers of these cells
infiltrating the CNS of infected B6 mice. Since trafficking
of GzmB CD8 cells into the infected CNS is not im-
paired, our data suggest that the delayed clearance of
LCMV from the brains of i.c.-infected GzmB mice is due
to an inability of GzmB CTL to eliminate LCMV-infected
cells in vivo.
Several studies have shown that the predominant
mechanism of CTL-mediated control of tumor cells is
perforin-dependent (Davis et al., 2001; Smyth et al., 2000;
van den Broek et al., 1996). However, the use of gene-
targeted mice has revealed unsuspected complexities in
the interaction between CTL and virus-infected cells in
vivo. Whereas viruses such as ectromelia and MCMV
require both perforin and granzymes for effective control
(Mu¨llbacher et al., 1996, 1999; Riera et al., 2000), control
of vesicular stomatitis virus can be effected by GzmB
independent of perforin (Hommel-Berrey et al., 1997). We
have shown that clearance of LCMV, although exquisitely
dependent on perforin expression, is also facilitated by
GzmB. It is likely that the disparate requirements for
CTL-mediated control of different viruses is likely to be
determined by factors such as the mode of replication of
the virus as well as the cell type that is infected in vivo.
MATERIALS AND METHODS
Viruses and cell lines
The Armstrong-3 strain of LCMV was obtained from
J. L. Whitton (The Scripps Research Institute, La Jolla, CA)
and was propagated in BHK-21 cells (American Type
Culture Collection, Rockville, MD), and infectious super-
natants were titrated on Vero cell monolayers as previ-
ously described (Ahmed et al., 1984). The fibroblastoid
MC57 (H-2b) and L cell (H-2k) lines have been described
previously (Muller et al., 1992). MC57 cells were cultured
in HEPES-buffered RPMI-1640 supplemented with 10%
FCS, and 50 M 2-mercaptoethanol (complete medium)
(Life Technologies Inc., Gaithersburg, MD) and L cells
were propagated in Dulbecco’s modified Eagle’s medium
(Life Technologies Inc.), which was also supplemented
with 10% FCS and 50 M 2-mercaptoethanol.
Treatment of mice
C57BL/6J (B6), B6;129S-Gzmbtm1Ley (GzmB) (Heusel et
al., 1994), C57BL/6-Pfptm1Sdz (Pfp) (Ka¨gi et al., 1994a), and
B6129SF2/J mice were obtained from Jackson Laborato-
ries (Bar Harbor, ME) and were maintained in specific
pathogen-free, AAALAC-accredited facilities at Loyola
University Medical Center, Maywood, IL. Female mice
were used at 7–20 weeks of age. Mice were infected via
the ip route with 2  105 plaque forming units (PFU) of
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LCMV in a volume of 0.4 ml. Spleens and livers were
removed from mice at the indicated time points following
ip infection with LCMV for determination of viral titers.
The tissues were homogenized and viral titers in the
supernatants were measured by plaque assay on Vero
cell monolayers as previously described (Ahmed et al.,
1984).
In experiments to assess the efficacy of secondary
antiviral CTL responses, mice that had been infected ip
with 2  105 PFU LCMV 3 months earlier were anesthe-
tized using Metofane (Pittman-Moore, Mundelein, IL) and
were rechallenged by i.c. injection of either 2  103 or
2  105 PFU LCMV in a volume of 20 l. Following i.c.
infection, mice were monitored daily for morbidity and
mortality. At the indicated time points following i.c. infec-
tion, mice were sacrificed and perfused with ice-cold
phosphate-buffered saline (PBS), and brains were har-
vested. A portion of each brain was taken for determina-
tion of viral titers as outlined above. Mononuclear cells
were isolated from the remaining portion of each brain
as described below. In certain experiments mice were
depleted of CD8 cells prior to infection by ip injection of
anti-CD8 antibody (clone 2.43) as previously described
(Su et al., 1998). This treatment removed 95% of the
CD8 cells as assessed by flow cytometry.
Cytotoxicity assays
Spleens were removed from mice 8 days following ip
infection with LCMV. The spleens were disrupted in com-
plete medium and erythrocytes were removed by os-
motic lysis. These effector cells were assayed for LCMV-
specific CTL activity using standard 51Cr-release assays
as previously described (Muller et al., 1992). The target
cell lines used in these assays were LCMV-infected and
mock-infected MC57 and L cell lines. Infection of MC57
cells and L cells with LCMV was performed exactly as
described previously (Muller et al., 1992). Effector cells
were incubated with the target cells for 4 or 8 h at 37°C
in 6% CO2. Supernatants were harvested using a Skatron
harvesting system (Skatron Instruments, Sterling, VA)
and the amount of 51Cr released was quantified using a
Packard -counter (Packard Instruments, Sterling, VA).
All assays were performed in triplicate and the percent-
age specific lysis was determined using the formula: %
specific lysis  {[(c.p.m. released in the presence of
effectors)  (spontaneous release)]/[(total release) 
(spontaneous release)]} 100, where total release is the
c.p.m. released from target cells by addition of 5% (v/v)
Triton X-100 (final concentration), and spontaneous re-
lease is the c.p.m. released from target cells in the
absence of effectors.
To measure CTL-mediated target cell DNA degrada-
tion, we used the JAM assay (Matzinger, 1991). MC57
cells and L cells were infected with LCMV as described
previously (Muller et al., 1992) except that during the final
3 h of the infection period the cells were labeled using 3
Ci/ml methyl-3H-thymidine. After washing with com-
plete medium, the labeled target cells were incubated
with effector cells for 4 or 8 h at 37°C in 6% CO2.
Following the incubation, the cells were harvested using
a Skatron Cell Harvester (Skatron Instruments) and the
amount of DNA-associated radiolabel remaining was
determined using a Packard -Counter (Packard Instru-
ments). The percentage of 3H-DNA released was calcu-
lated using the formula: % 3H  DNA-release  {[(c.p.m.
remaining without effectors)  (c.p.m. remaining with
effectors)]/(c.p.m. remaining without effectors)}  100.
Isolation of mononuclear cells from brains
Mononuclear cells were isolated from brains essen-
tially as described previously (Hawke et al., 1998). Brains
were harvested from mice as outlined above and were
disrupted in complete medium by passage through a
sterile mesh (100-m pore size, Becton–Dickinson, San
Jose, CA) and by successive passages through 19- and
21-gauge needles (Becton–Dickinson). Cell suspensions,
each derived from a single animal, were centrifuged at
700 g (at 4°C) for 7 min and the pellets were resus-
pended in 3 ml of a Percoll solution composed of a 10:1
mixture of Percoll (Sigma Chemical Co., St. Louis, MO)
and 10 RPMI. Dilutions of 60, 40, and 0% of this Percoll
solution were overlaid on top of the cell suspensions.
Following centrifugation for 15 min at 1000 g (at 4°C),
mononuclear cells were harvested from the 40–60% in-
terface. Cells were washed three times with complete
medium prior to use in ELISPOT as described below.
ELISPOT to enumerate cytokine secreting cells
The numbers of cells reactive against the immuno-
dominant major histocompatibility complex (MHC) class
I and MHC class II restricted epitopes of LCMV in
spleens or brains of infected mice were determined
using an interferon- (IFN-) ELISPOT exactly as de-
scribed previously (Kamperschroer and Quinn, 1999).
Cells were prepared from infected mice as outlined
above and were serially diluted in complete medium to
give a range of cell numbers per well. Each dilution of
effector cells was assayed in duplicate or triplicate.
Wells also contained 50 units/ml of recombinant human
IL-2 (Sigma Chemical Co.) and 1  106 syngeneic stim-
ulator spleen cells together with the appropriate pep-
tides. Peptides corresponding to amino acids 33–41, 61–
80, and 276–286 of the LCMV glycoprotein (GP), and to
309–328 and 396–404 of the LCMV nucleoprotein (NP),
were synthesized by the Loyola University Macromolec-
ular Synthesis Facility using a Synergy 432A automated
synthesizer. The LCMV class I restricted peptides, GP33-
41, GP276-286, and NP396-404 (Oldstone et al., 1988;
Whitton et al., 1988a,b), were added at 1 g/ml and the
LCMV class II restricted peptides, GP61-80 and NP309-
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328 (Oxenius et al., 1998), were added at 10 g/ml.
Previous work in this laboratory has shown these to be
the optimal concentrations of the respective peptides for
use in ELISPOT. Control wells were treated as described
above except that no peptide was added. The ELISPOT
assays were developed and spots were counted as
described previously (Kamperschroer and Quinn, 1999).
Results were expressed as the total numbers of peptide-
specific IFN--secreting cells in the spleens of infected
animals or as the numbers of peptide specific IFN--
secreting cells per gram of brain.
Flow cytometry
Aliquots of cells in ice-cold PBS supplemented with 1%
(v/v) FCS and 15 mM sodium azide (FACS buffer) were
incubated with PE-conjugated anti CD4 (clone RM4-5;
BD-Pharmingen, San Diego, CA) and FITC-anti-CD8
(clone 53-6.7; BD-Pharmingen) at a concentration of 1
g/106 cells, for 30 min at 4°C. Samples were washed
with FACS buffer and analyzed using a FACSCalibur flow
cytometer (Becton–Dickinson). Dead cells were ex-
cluded on the basis of forward and side scatter, and data
analysis was performed on 10,000 acquired events using
the computer program CellQuest (Becton–Dickinson).
Statistical analyses
The Student’s t test was used to compare control with
experimental groups. Values of P  0.05 were consid-
ered not significant.
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